MX2010009961A - Composicion transmucosica mejorada y forma de dosificacion. - Google Patents
Composicion transmucosica mejorada y forma de dosificacion.Info
- Publication number
- MX2010009961A MX2010009961A MX2010009961A MX2010009961A MX2010009961A MX 2010009961 A MX2010009961 A MX 2010009961A MX 2010009961 A MX2010009961 A MX 2010009961A MX 2010009961 A MX2010009961 A MX 2010009961A MX 2010009961 A MX2010009961 A MX 2010009961A
- Authority
- MX
- Mexico
- Prior art keywords
- dosage form
- active compound
- transmucosal
- composition
- osmolality
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000004615 ingredient Substances 0.000 abstract 2
- 206010020852 Hypertonia Diseases 0.000 abstract 1
- 239000003833 bile salt Substances 0.000 abstract 1
- ZISSAWUMDACLOM-UHFFFAOYSA-N methyl-t-butylethan Natural products CC(C)C(C)(C)C ZISSAWUMDACLOM-UHFFFAOYSA-N 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 229960003708 sumatriptan Drugs 0.000 abstract 1
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 abstract 1
- -1 triptan compound Chemical class 0.000 abstract 1
- 229960001360 zolmitriptan Drugs 0.000 abstract 1
- UTAZCRNOSWWEFR-ZDUSSCGKSA-N zolmitriptan Chemical compound C=1[C]2C(CCN(C)C)=CN=C2C=CC=1C[C@H]1COC(=O)N1 UTAZCRNOSWWEFR-ZDUSSCGKSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6941408P | 2008-03-14 | 2008-03-14 | |
| PCT/US2009/001626 WO2009114192A2 (en) | 2008-03-14 | 2009-03-13 | Enhanced transmucosal composition and dosage form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010009961A true MX2010009961A (es) | 2010-09-30 |
Family
ID=41065734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010009961A MX2010009961A (es) | 2008-03-14 | 2009-03-13 | Composicion transmucosica mejorada y forma de dosificacion. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110021583A1 (enExample) |
| EP (1) | EP2265250A2 (enExample) |
| JP (1) | JP2011514358A (enExample) |
| CA (1) | CA2717984C (enExample) |
| MX (1) | MX2010009961A (enExample) |
| WO (1) | WO2009114192A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3316865A4 (en) | 2015-07-02 | 2019-01-23 | Civitas Therapeutics, Inc. | TRIPTAN POWDER FOR PULMONARY ADMINISTRATION |
| CA3166250A1 (en) * | 2020-02-05 | 2021-08-12 | Gregory G. Plucinski | Drug products for intranasal administration and uses thereof |
| WO2026050777A2 (en) * | 2024-09-01 | 2026-03-05 | Sandipkumar Patel | Stable liquid formulations of frovatriptan |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968507A (en) * | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
| JPH11292787A (ja) * | 1995-08-15 | 1999-10-26 | Asahi Chem Ind Co Ltd | 生理活性ペプチドを含有する経粘膜投与製剤 |
| US6255502B1 (en) * | 1996-07-11 | 2001-07-03 | Farmarc Nederland B.V. | Pharmaceutical composition containing acid addition salt of basic drug |
| TWI243687B (en) * | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| US6210699B1 (en) * | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
| AR026072A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
| AU2023401A (en) * | 1999-12-01 | 2001-06-12 | Natco Pharma Limited | A rapid acting freeze dired oral pharmaceutical composition for treating migraine |
| US20020147232A1 (en) * | 2000-05-26 | 2002-10-10 | Claus Sundgreen | Pharmaceutical compositions comprising desglymidodrine as an active drug substance |
| WO2004093917A2 (en) * | 2003-04-22 | 2004-11-04 | Nastech Pharmaceutical Company Inc. | Intranasal administration of triptans |
| US20060002989A1 (en) * | 2004-06-10 | 2006-01-05 | Ahmed Salah U | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| US20060193908A1 (en) * | 2004-11-09 | 2006-08-31 | Burnside Beth A | Extended release formulations of poorly soluble antibiotics |
| WO2007096906A2 (en) * | 2006-02-27 | 2007-08-30 | Panacea Biotec Ltd. | Novel buccoadhesive compositions and process of preparation thereof |
-
2009
- 2009-03-13 WO PCT/US2009/001626 patent/WO2009114192A2/en not_active Ceased
- 2009-03-13 JP JP2010550703A patent/JP2011514358A/ja active Pending
- 2009-03-13 EP EP09719448A patent/EP2265250A2/en not_active Withdrawn
- 2009-03-13 MX MX2010009961A patent/MX2010009961A/es not_active Application Discontinuation
- 2009-03-13 CA CA2717984A patent/CA2717984C/en not_active Expired - Fee Related
-
2010
- 2010-08-23 US US12/860,978 patent/US20110021583A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2717984A1 (en) | 2009-09-17 |
| US20110021583A1 (en) | 2011-01-27 |
| WO2009114192A2 (en) | 2009-09-17 |
| EP2265250A2 (en) | 2010-12-29 |
| JP2011514358A (ja) | 2011-05-06 |
| WO2009114192A3 (en) | 2010-07-08 |
| CA2717984C (en) | 2013-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
| MX2011013201A (es) | Composiciones para tratar adiccion a drogas y para mejorar comportamiento relacionado a la adiccion. | |
| EA201190127A1 (ru) | Фармацевтические составы нитазоксанида с контролируемым высвобождением | |
| CL2010001260A1 (es) | Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis. | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| EA201500430A1 (ru) | Соединения боронатного эфира и его фармацевтические составы | |
| MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| SG178975A1 (en) | Indenone derivative and pharmaceutical composition comprising same | |
| PH12012500773A1 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
| GT200600160A (es) | Tratamiento del dolor | |
| EA200801731A1 (ru) | Составы и способы лечения тробмоцитемии | |
| TW200509992A (en) | Dosage form containing pantoprazole as active ingredient | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| MX339096B (es) | Compuestos inhibidores de metaloproteasa a base de feniletiniltiofeno y su uso en el tratamiento del dolor y otras enfermedades. | |
| WO2009114192A3 (en) | Enhanced transmucosal composition and dosage form | |
| TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
| EA201201528A1 (ru) | Комбинация ингибиторов ксантиноксидазы и антагонистов рецепторов ангиотензина-ii и ее применение | |
| TW200611697A (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
| FI20135503A7 (fi) | Kysteiini tai sen johdannainen atrofisen gastriitin hoitamiseen | |
| AR066667A1 (es) | Composiciones farmaceuticas que comrenden la combinacion de un agente derivado hidrogenado de lipstatina y un agente inhibidor de hmg coa reductasa | |
| TR201100151A2 (tr) | İbandronate formülasyonu. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |